NZX on front foot to start May as Infratil rises 3.5%
A late rally of Fisher & Paykel Healthcare, rising 2.44% to $34.83, helped push the S&P/NZX 50 up 2.06% to 12.148.600 points – over 44 million shares trading hands, amounting to $153.9m in value traded.
The equivalent index in Australia, the S&P/ASX 200, was down more than 10% for the year on April 7 but has more or less recovered since. Up another 0.2% by 5pm on Thursday, it is almost flat for the year.
Despite never being down 10% at any stage this year, the NZX 50 has not made the same recovery. It remained 7% down for the year at the end of the day's trading.
Head of retail investing at Devon Funds, Greg Smith, said part of the explanation is due to the NZX being more defensive and less directly exposed to China than the ASX.
Click the button below to subscribe and will have free unlimited access for a limited time to full article and all other articles on the site.
You will also be able to comment on articles on Good Returns.